News

Carbyne Equity Partners ("Carbyne") today announced that its portfolio company SuanNutra has signed an agreement to acquire IFF's Natural Solutions Business (NYSE: IFF), a portfolio of botanical extracts, vitamins and minerals, and food enhancement activities.

Carbyne Equity Partners is pleased to announce the acquisition of SuanNutra, the nutraceutical ingredients business of Suanfarma. This investment marks Carbyne’s entry into the nutraceutical sector.

Carbyne Equity Partners is pleased to announce that, as of November 27th, we have entered a strategic partnership with Chemia S.P.A., an established Italian supplier of biologicals and conventional crop protection products.

We are pleased to partner with Elicit Plant, a French agri-biotech company developing biosolutions to prevent drought stress on broad acre crops. This investment demonstrates our commitment to leveraging innovative solutions that address climate challenges in agriculture.

We are delighted to announce that we signed an agreement to acquire a majority stake in Biomapas, a leading European CRO. This partnership underscores our commitment to fostering growth and innovation in the life sciences sector.

Fight against cancer continues – we are delighted to announce our renewed investment in ITM Isotope Technologies Munich SE.

We are pleased to announce our investment in Fotokite AG.

Carbyne Equity Partners invests in ITM – Isotope Technologies Munich SE together with Temasek, BlackRock, QIA, Nextech and ATHOS.